Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

CitrixNews Staff

· September 30, 2026 at 5:48 PM

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Originally reported by New York Times. Read the full story at the original source.

A Republican measure to limit, but not bar, congressional stock trading faltered in the Senate as Democrats thwarted a G...

Senate Democrats were expected on Wednesday to block a measure that would encourage, but not require, states to protect ...

Senate Democrats have blocked a bill that seeks to address data center electricity costs, calling it ineffective and &#8...

Defense Secretary Pete Hegseth will lay out his priorities for the U.S. military Wednesday during the annual State of th...

Related Articles